Search company, investor...
Orthoscan company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Loan | Alive

Total Raised


Last Raised

$1.5M | 2 yrs ago

About Orthoscan

OrthoScan, Inc. manufactures the OrthoScan High Definition Mini C-Arm for extremity imaging. Designed for orthopedic surgeons, the small, lightweight C-arm configuration fluoroscopic system aims to provide real-time images with four times the resolution of other currently available fluoroscans. It can be used during surgical orthopedic procedures, and critical and emergency care procedures.OrthoScan, headquartered in Scottsdale, Arizona, uses state-of-the-art technologies to bring x-ray imaging in extremity surgery to a next level. For instance, innovative flat detectors in the latest product introduction named OrthoScan HD, allows reduction of distortions inherent with previous image intensifier technology, thereby improving significantly diagnostic accuracy. The mini C-Arms by OrthoScan provide the solution needed by orthopaedics and podiatrists for high-quality imaging in a small-scale device, facilitating complex surgeries on small and delicate body structures, such as wrists, knees and ankles. In September 2011, Orthoscan was acquired Aton, a German private investment firm. Orthoscan's valuation was not disclosed.

Orthoscan Headquarters Location

8212 East Evans Road

Scottsdale, Arizona, 85260,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Orthoscan

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Orthoscan is included in 3 Expert Collections, including Medical Devices.


Medical Devices

11,575 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,901 items

Orthoscan Patents

Orthoscan has filed 7 patents.

The 3 most popular patent topics include:

  • Medical imaging
  • Radiography
  • Radiology
patents chart

Application Date

Grant Date


Related Topics




Radiography, Medical imaging, Spectroscopy, Radiology, Projectional radiography


Application Date


Grant Date



Related Topics

Radiography, Medical imaging, Spectroscopy, Radiology, Projectional radiography



Latest Orthoscan News

C-Arms Global Market Report 2022

Jun 6, 2022

" - and OrthoScan Inc.), Hologic Inc., Fujifilm Holdings Corporation, OrthoScan Inc., Assing S.p.A, AADCO Medical Inc., Villa Sistemi Medicali Spa, Varian Medical Systems Inc., Toshiba Corp., Omega Medical Imaging Inc., and BMI Biomedical International. The global C-arms market is expected to grow from $1.97 billion in 2021 to $2.05 billion in 2022 at a compound annual growth rate (CAGR) of 4.39%. The growth is mainly due to the companies’ resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $2.41 billion in 2026 at a CAGR of 4.15%. The c-arms market consists of sales of c-arms by entities (organizations, sole traders, and partnerships) that refer to an imaging scanner intensifier that is used in several diagnostic and interventional procedures based on X-ray technology.C-arms are C-shaped arms that have radiographic capabilities. These are used in fluoroscopic intraoperative imaging in emergency care, surgical care, and orthopedic procedures. The main types of C-arms are fixed C-arms and mobile C-arms.Fixed C-arms are large C-arms that are designed for a wide array of health care applications. Mobile C-arms are smaller and more compact C-arms that can be used flexibly in various operating rooms within a clinic for a variety of diagnostic imaging and minimally invasive surgical procedures.The various C-arm detectors include image intensifiers and flat panel detectors used for applications including cardiology, gastroenterology, neurology, orthopedics, trauma, oncology and other applications. The different C-arm end users are hospitals, diagnostic centers, speciality clinics, and others. North America was the largest region in the C-arms market in 2020.Asia-Pacific is expected to be the fastest growing market in the C-arms market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The increasing incidence of chronic diseases is expected to propel the growth of the C-arms market.There is an increase in the incidence of chronic diseases such as heart diseases, cancer, diabetes, obesity, arthritis, Alzheimer’s, and epilepsy. C-arms are used for fluoroscopic imaging during surgical and orthopaedic procedures. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 868,000 Americans will die each year from heart strokes and heart diseases by June 2021.According to the International Diabetes Federation in 2020, 463 million adults are suffering from diabetes, among whom 10.0% are suffering from type 1 diabetes and 90.0% from type 2 diabetes. Therefore, the increasing incidence of chronic diseases drives the C-arms market. Technological developments are a key trend gaining popularity in the C-arms market.There are many technological developments in the C-arm market, and many companies are launching new products and bringing innovations to their C-arm platforms. For instance, in 2020, Dutch multinational conglomerate corporation, Philips, announced two major innovations to its Zenition mobile C-arm platform that include a new Table Side User Interface, allowing the clinician to operate the C-arm inside the sterile field, and an extension integrating intravascular ultrasound (IVUS) for peripheral vascular procedures, streamlining the operating room and improving workflow. In April 2019, Ziehm Imaging, a Germany-based mobile C-arm manufacturer, partnered with Carestream Health.Through this partnership, Ziehm Imaging would be able to provide Carestream Health and its customers with innovative C-arms (Ziehm Vision RFD C-arm) that will provide exceptional image quality and will also reduce exposure significantly with the next-generation SmartDose. Carestream Health is a USA-based provider of medical imaging involving C-arms. The countries covered in the C-arms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Orthoscan Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Orthoscan Rank

  • When was Orthoscan founded?

    Orthoscan was founded in 2002.

  • Where is Orthoscan's headquarters?

    Orthoscan's headquarters is located at 8212 East Evans Road, Scottsdale.

  • What is Orthoscan's latest funding round?

    Orthoscan's latest funding round is Loan.

  • How much did Orthoscan raise?

    Orthoscan raised a total of $9.1M.

  • Who are the investors of Orthoscan?

    Investors of Orthoscan include Paycheck Protection Program, Aton, California Technology Ventures, River Cities Capital Fund and Aphelion Capital.

  • Who are Orthoscan's competitors?

    Competitors of Orthoscan include EPIX Therapeutics, MAKO Surgical, Orthovita, IMRIS, Kjaya and 12 more.

You May Also Like

VasoLux Microsystems

VasoLux MicroSystems, LLC has developed a diagnostic imaging system to help surgeons identify later-stage osteoarthritis patients who are best suited for cartilage repair procedures or joint replacement surgery.


EXCMR develops medical devices to enhance cardiovascular magnetic resonance imaging (MRI). The company has developed an MRI-compatible treadmill that aims to allow cardiovascular exercise stress testing with MRI, giving doctors pictures of the heart immediately following peak exercise stress. MRI shows both heart function and perfusion (blood flow to the heart muscle) with higher resolution and clarity than available with other imaging tests. Symptoms, like chest pain, caused by coronary artery blockages often can be reproduced only with exercise-induced stress. Images of the heart taken immediately after exercise allow doctors to examine the pumping action and blood flow at rest and stress to more accurately determine the cause of symptoms. The MRI-compatible treadmill aims to allow for the first time the combination of exercise stress testing with magnetic resonance imaging. EXCMR was specifically formed to provide commercial production and distribution of the treadmill.

Pulse Metric

Pulse Metric designs, manufactures and markets products and services that transform a simple blood pressure reading into a powerful functional profile of the patients cardiovascular system, including cardiac output, vessel compliance, vascular resistance and left ventricular contractility. Within a minute of uploading a DynaPulse blood pressure waveform to the DynaPulse Analysis Center website, 17 hemodynamic parameters are calculated, displayed and trended, providing clinicians with numeric values profiling the hearts pumping performance, blood vessel elasticity and vascular resistance, against normative ranges.The company believes the simplicity of its methodology and the significance of the information provided to the physician will improve quality of care while reducing costs. Pulse Metric has been granted nine patents in support of its proprietary technology.


Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

TrueVision Systems

TrueVision Systems, dba TrueVisions 3D Surgical, provides digital 3D visualization and guidance for microsurgery. The company has developed an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. The company is developing 3D guidance applications for microsurgery to improve surgical efficiencies and patient outcomes. The Refractive Cataract Toolset is a computer-aided software for astigmatic correction and advanced IOL positioning.


Celsense is a biotechnology company offering MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have application in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with pharmaceutical and biotechnology organizations and is developing products suitable for human use.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.